Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Using vaginal Group B Streptococcus colonisation in women with preterm premature rupture of membranes to guide the decision for immediate delivery: a secondary analysis of the PPROMEXIL trials.
Tajik P, van der Ham DP, Zafarmand MH, Hof MH, Morris J, Franssen MT, de Groot CJ, Duvekot JJ, Oudijk MA, Willekes C, Bloemenkamp KW, Porath M, Woiski M, Akerboom BM, Sikkema JM, Nij Bijvank B, Mulder AL, Bossuyt PM, Mol BW. Tajik P, et al. Among authors: sikkema jm. BJOG. 2014 Sep;121(10):1263-72; discussion 1273. doi: 10.1111/1471-0528.12889. Epub 2014 May 27. BJOG. 2014. PMID: 24862166 Clinical Trial.
Management of late-preterm premature rupture of membranes: the PPROMEXIL-2 trial.
van der Ham DP, van der Heyden JL, Opmeer BC, Mulder AL, Moonen RM, van Beek JH, Franssen MT, Bloemenkamp KW, Sikkema JM, de Groot CJ, Porath M, Kwee A, Woiski MD, Duvekot JH, Akerboom BM, van Loon AJ, de Leeuw JW, Willekes C, Mol BW, Nijhuis JG. van der Ham DP, et al. Among authors: sikkema jm. Am J Obstet Gynecol. 2012 Oct;207(4):276.e1-10. doi: 10.1016/j.ajog.2012.07.024. Epub 2012 Jul 20. Am J Obstet Gynecol. 2012. PMID: 22901981 Clinical Trial.
Vaginal birth after a caesarean section: the development of a Western European population-based prediction model for deliveries at term.
Schoorel EN, van Kuijk SM, Melman S, Nijhuis JG, Smits LJ, Aardenburg R, de Boer K, Delemarre FM, van Dooren IM, Franssen MT, Kaplan M, Kleiverda G, Kuppens SM, Kwee A, Lim FT, Mol BW, Roumen FJ, Sikkema JM, Smid-Koopman E, Visser H, Woiski M, Hermens RP, Scheepers HC. Schoorel EN, et al. Among authors: sikkema jm. BJOG. 2014 Jan;121(2):194-201; discussion 201. doi: 10.1111/1471-0528.12539. BJOG. 2014. PMID: 24373593
Economic analysis comparing induction of labor and expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial).
Vijgen SM, van der Ham DP, Bijlenga D, van Beek JJ, Bloemenkamp KW, Kwee A, Groenewout M, Kars MM, Kuppens S, Mantel G, Molkenboer JF, Mulder AL, Nijhuis JG, Pernet PJ, Porath M, Woiski MD, Weinans MJ, van Wijngaarden WJ, Wildschut HI, Akerboom B, Sikkema JM, Willekes C, Mol BW, Opmeer BC; PPROMEXIL study group. Vijgen SM, et al. Among authors: sikkema jm. Acta Obstet Gynecol Scand. 2014 Apr;93(4):374-81. doi: 10.1111/aogs.12329. Epub 2014 Jan 29. Acta Obstet Gynecol Scand. 2014. PMID: 24392746 Free article.
Predicting successful intended vaginal delivery after previous caesarean section: external validation of two predictive models in a Dutch nationwide registration-based cohort with a high intended vaginal delivery rate.
Schoorel EN, Melman S, van Kuijk SM, Grobman WA, Kwee A, Mol BW, Nijhuis JG, Smits LJ, Aardenburg R, de Boer K, Delemarre FM, van Dooren IM, Franssen MT, Kleiverda G, Kaplan M, Kuppens SM, Lim FT, Sikkema JM, Smid-Koopman E, Visser H, Vrouenraets FP, Woiski M, Hermens RP, Scheepers HC. Schoorel EN, et al. Among authors: sikkema jm. BJOG. 2014 Jun;121(7):840-7; discussion 847. doi: 10.1111/1471-0528.12605. Epub 2014 Feb 18. BJOG. 2014. PMID: 24533534
Economic analysis of use of pessary to prevent preterm birth in women with multiple pregnancy (ProTWIN trial).
Liem SM, van Baaren GJ, Delemarre FM, Evers IM, Kleiverda G, van Loon AJ, Langenveld J, Schuitemaker N, Sikkema JM, Opmeer BC, van Pampus MG, Mol BW, Bekedam DJ. Liem SM, et al. Among authors: sikkema jm. Ultrasound Obstet Gynecol. 2014 Sep;44(3):338-45. doi: 10.1002/uog.13432. Epub 2014 Aug 7. Ultrasound Obstet Gynecol. 2014. PMID: 24898103 Free article.
Second-trimester cervical length as risk indicator for Cesarean delivery in women with twin pregnancy.
van de Mheen L, Schuit E, Liem SM, Lim AC, Bekedam DJ, Goossens SM, Franssen MT, Porath MM, Oudijk MA, Bloemenkamp KW, Duvekot JJ, Woiski MD, de Graaf I, Sikkema JM, Scheepers HC, van Eijk J, de Groot CJ, van Pampus MG, Mol BW. van de Mheen L, et al. Among authors: sikkema jm. Ultrasound Obstet Gynecol. 2015 Nov;46(5):579-84. doi: 10.1002/uog.14727. Epub 2015 Aug 18. Ultrasound Obstet Gynecol. 2015. PMID: 25402630 Free article.
Patient controlled analgesia with remifentanil versus epidural analgesia in labour: randomised multicentre equivalence trial.
Freeman LM, Bloemenkamp KW, Franssen MT, Papatsonis DN, Hajenius PJ, Hollmann MW, Woiski MD, Porath M, van den Berg HJ, van Beek E, Borchert OW, Schuitemaker N, Sikkema JM, Kuipers AH, Logtenberg SL, van der Salm PC, Oude Rengerink K, Lopriore E, van den Akker-van Marle ME, le Cessie S, van Lith JM, Struys MM, Mol BW, Dahan A, Middeldorp JM. Freeman LM, et al. Among authors: sikkema jm. BMJ. 2015 Feb 23;350:h846. doi: 10.1136/bmj.h846. BMJ. 2015. PMID: 25713015 Free PMC article. Clinical Trial.
Preventing Preterm Birth with Progesterone in Women with a Short Cervical Length from a Low-Risk Population: A Multicenter Double-Blind Placebo-Controlled Randomized Trial.
van Os MA, van der Ven AJ, Kleinrouweler CE, Schuit E, Kazemier BM, Verhoeven CJ, de Miranda E, van Wassenaer-Leemhuis AG, Sikkema JM, Woiski MD, Bossuyt PM, Pajkrt E, de Groot CJ, Mol BW, Haak MC. van Os MA, et al. Among authors: sikkema jm. Am J Perinatol. 2015 Aug;32(10):993-1000. doi: 10.1055/s-0035-1547327. Epub 2015 Mar 4. Am J Perinatol. 2015. PMID: 25738790 Clinical Trial.
Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial.
Broekhuijsen K, van Baaren GJ, van Pampus MG, Ganzevoort W, Sikkema JM, Woiski MD, Oudijk MA, Bloemenkamp KW, Scheepers HC, Bremer HA, Rijnders RJ, van Loon AJ, Perquin DA, Sporken JM, Papatsonis DN, van Huizen ME, Vredevoogd CB, Brons JT, Kaplan M, van Kaam AH, Groen H, Porath MM, van den Berg PP, Mol BW, Franssen MT, Langenveld J; HYPITAT-II study group. Broekhuijsen K, et al. Among authors: sikkema jm. Lancet. 2015 Jun 20;385(9986):2492-501. doi: 10.1016/S0140-6736(14)61998-X. Epub 2015 Mar 25. Lancet. 2015. PMID: 25817374 Clinical Trial.
33 results